Fictional specimen · Project Aster · exact delivery format · no live client data
Skip to report

IC cover — the decision record: an explicit recommendation and its conditions, for a committee that wants it written.Compare · Project Meridian · defer

Recommendation

Approve with conditions

Commitment US$750,000 · US$12.0m post-money company valuation cap

Go to decision ask
Digital assets · Investment committee · Confidential

Investment Committee
Cover Memorandum

Project Aster · fictional specimen   /   IC Cover Memorandum

Project Aster · Proposed US$750,000 SAFT+T investment in digital-asset settlement infrastructure, including companion rights to 43,750,000 future AQY tokens.

Decision use
Investment approval and funding conditions
Recommendation
Approve with conditions
Evidence
Public + private verification
Cutoff 14 September 2026
Prepared for / by
Commissioning investor
Luis Fontana · Mjolnir Capital

Confidential report simulation. Project Aster is fully fictional; every entity, person, source and figure is synthetic. The analytical form, evidence treatment and decision language match the intended client deliverable. Informational only — not an offer or solicitation. The commissioning investor retains the final decision.

Decision ask

Recommendation · Approve with conditions

Approve a US$750,000 SAFT+T commitment at a US$12,000,000 post-money cap, subject to CP1–CP4 and quarterly underwriting refresh.

The reconciled operating record and synthetic DR10 underwriting bridge support a conditional pass: Year-5 revenue is driver-built from 400 active accounts at US$30,000 annual revenue/account, producing a US$120,000,000 equity-value scenario at a 10.0× direct equity/revenue scenario multiple. Give the future token no value.

Initial ownership
6.25%
US$750,000 ÷ US$12,000,000 post-money cap; before future dilution.
Token entitlement
4.375%
43,750,000 tokens of 1,000,000,000 genesis supply; value set to zero.
Base case
6.50×
US$4,875,000 equity proceeds; 45.41% five-year gross IRR.
Approval boundary. Funding remains subject to CP1–CP4, quarterly driver refresh, OP1 processor diversification and no value assigned to AQY.

Transaction and mandate fit

ItemExact termIC treatment
Investor commitmentUS$750,000Within the fictional mandate’s US$1,000,000 initial-check maximum.
RoundUS$2,400,000Lead allocation equals 31.25% of the round.
InstrumentSAFT+T packageFuture-equity conversion right plus companion token warrant; final counsel review required.
Company valuationUS$12,000,000 post-money cap6.25% initial company ownership before future dilution.
Token right43,750,000 of 1,000,000,000 genesis tokens4.375%; 12-month lock then monthly vesting over 24 months.
Reserve postureUS$750,000 reserved1.0× initial commitment; follow-on requires milestone review.
Holding period5 yearsUsed for equity-only outcome analysis.
Mandate fitPassSeed digital infrastructure; ownership exceeds 5.00% minimum and check is within limit.

Investment thesis

1 · Evidence of demand

Q2 payment volume of US$26,400,000 reconciles to processor records. Forty-two businesses transacted at cutoff, and the January customer cohort retained 25 of 30 accounts after six months.

2 · Improving revenue quality

Q2 net revenue is US$213,840 at a 0.81% realized net take rate. LTM net revenue is US$612,000, annualized Q2 revenue is US$855,360, and gross margin is 67%.

3 · Defensible workflow position

The product sits between treasury teams and regulated payment providers without taking custody. Contractual integrations, reconciliation tooling and customer workflows create switching cost.

4 · Token optionality kept separate

The future token supports operator bonding and fee rebates, but is not live. No token price, listing, liquidity or treasury value appears in the return case.

Underwriting bridge

A synthetic underwriting record connects the observed US$612,000 LTM base to a bottom-up Year-5 scenario and makes the conditional-pass assumptions explicit. Business judgment rests on paying usage, retention and partner-sourced customer acquisition; transaction judgment remains conditional on CP1–CP4, OP1 and enforceable rights. Social following is not a demand proxy for this B2B settlement case.

WorkstreamSynthetic evidence in roomConditional-pass treatment
MarketDR10 defines four launch corridors and a focused wedge before expansion.Bounded bottom-up scenario; no top-down TAM claim; quarterly corridor refresh.
CompetitionDR10 maps incumbent processor, treasury middleware and corridor specialist archetypes.Qualitative differentiation only; named win/loss benchmark remains follow-on.
DistributionDR10 models 80 / 140 / 205 / 264 / 400 ending accounts in Years 1–5, approximately 75% annual retention, and 48 / 80 / 100 / 110 / 202 new accounts. The Year-5 jump to 202 new accounts is an unproven execution stretch.Scenario only; test the Year-5 202-account acquisition step, CAC, retention and OP1 quarterly.
TeamTwo-founder product/operations base plus Year-1 sales/compliance and Year-3 finance hires.Hiring and key-person milestones remain monitored.
Exit bridge400 accounts × US$30,000 annual revenue/account = US$12m Year-5 revenue; 10.0× direct equity/revenue scenario multiple = US$120m equity value.Scenario input; no probability weighting or token value.
Underwriting boundary. DR10 is synthetic scenario evidence, not external market proof. It supports a conditional pass only with CP1–CP4, OP1, quarterly driver refresh and no AQY value.

Evidence supporting approval

TestResultIC conclusion
Revenue populationUS$213,840 Q2 revenue ties to 0.81% of US$26.4m processor volume and to ledger/bank samples.Supported
Customer activity51 contracted; 42 transacting; six references: five positive, one neutral.Supported with concentration monitoring
RetentionJanuary cohort 25 of 30 active at month six = 83.33%; US$100,000 month-0 revenue became US$118,000 at month six = 118.00% NRR.Supported · Findings!C12:C13 · DR04
Cash and runwayUS$610,000 cash less US$160,000 liabilities plus US$2.31m net financing = US$2.76m. At US$138,000 planned monthly burn: 20.00 months.Supported · Financial model!C26:C32
Ownership and IPCap table, board authority and IP assignments reconcile.Supported
SecurityIndependent audit reports no open critical finding and one high-severity item remediated.Condition: final retest letter
TokenAllocation sums to 100%; investor right is arithmetically defined.Contractual and pre-deployment; value excluded

Valuation and outcomes

Price the operating company; derive the dilution; do not smuggle token speculation into the base case.

MeasureCalculationResult
Initial company ownershipUS$750,000 ÷ US$12,000,0006.2500%
Modeled ownership at exit6.2500% × 65.00% retained — derived below4.0625%
Entry / LTM net revenueUS$12,000,000 ÷ US$612,00019.61× · Financial model!E20
Entry / annualized Q2 net revenueUS$12,000,000 ÷ US$855,36014.03× · Financial model!E21
Token value in all cases43,750,000 × US$0US$0

Dilution bridge

The exit ownership is derived, not assumed. Dilution is the most leveraged input in the return case, so the path that produces 65.00% retained ownership is stated in full.

EventDilution at eventInvestor ownership afterBasis
At close — SAFT+T conversion—6.2500%US$750,000 ÷ US$12,000,000 post-money cap.
Series A, including option-pool refresh18.75%5.0781%6.2500% × 81.25% retained.
Series B, including option-pool refresh20.00%4.0625%5.0781% × 80.00% retained.
Cumulative to Year 535.00%4.0625%81.25% × 80.00% = 65.00% retained.
Dilution basis. The two priced rounds above are a synthetic financing path, not a committed schedule. They are stated so the 35.00% modeled dilution can be tested rather than accepted: each round is shown inclusive of its option-pool refresh, and no bridge, converting instrument or secondary is assumed. A committee that underwrites a heavier path should substitute its own retention factor — at 45.00% cumulative dilution the base case returns 5.50× and 40.63%, and at 55.00% it returns 4.50× and 35.10%, against 6.50× and 45.41% as modeled.

Scenario construction

Each case is built from the same two drivers as the base case — Year-5 ending accounts and net revenue per account — then priced on a stated multiple. No case is asserted as a value.

CaseYear-5 ending accountsNet revenue / accountYear-5 net revenueEquity / revenue multipleYear-5 equity value
Downside180US$25,000US$4,500,0002.0×US$9,000,000
Base400US$30,000US$12,000,00010.0×US$120,000,000
Upside600US$40,000US$24,000,00015.0×US$360,000,000
Multiples are IC inputs, not comparables. The 2.0× / 10.0× / 15.0× scenario multiples are committee inputs. No external comparable-company or comparable-transaction evidence is within this engagement's scope, and none is asserted. The downside holds retention but assumes the Year-5 202-account acquisition step fails and pricing concedes to processor competition, so it is priced as a constrained sale rather than a growth transaction. Substituting a different multiple changes the equity value and proceeds; it does not change the ownership, dilution or reperformance arithmetic.

Outcomes

CaseYear-5 company equity valueInvestor proceedsGross MOIC5-year gross IRR
DownsideUS$9,000,000US$365,6250.4875×−13.38%
BaseUS$120,000,000US$4,875,0006.5000×45.41%
UpsideUS$360,000,000US$14,625,00019.5000×81.14%

Gross, pre-tax, pre-fee scenario outputs. Exit value is applied to 4.0625% modeled ownership after 35.00% dilution, derived in the bridge above. No probability weighting and no token, treasury, staking or liquidity value.

Risks and mitigants

PriorityRiskMitigant / IC treatment
HighTop five customers produce 38.00% of Q2 volume; the largest produces 9.47% of Q2 net revenue.Quarterly concentration report; 25.00% single-customer revenue escalation threshold.
HighRegulatory treatment varies by corridor and token design.Jurisdiction-specific counsel opinion and distribution restrictions before closing/TGE.
HighAQY utility, launch timing and liquidity are unproven.Assign zero token value; no launch or listing assumption in returns.
HighProduction key, oracle and contract controls can fail.Independent audit closure, 2-of-3 multisig, pause, rotation and incident procedures.
MediumThe largest processor handles 64.00% of Q2 volume.OP1: Processor-B live in each new corridor before its funded expansion.
MediumPlanned burn rises from US$92,000 to US$138,000 monthly.Monthly budget-to-actual reporting and 12-month minimum runway alert.

Conditions precedent and ownership

#ConditionOwnerEvidence / pass test
CP1Final SAFT+T and corporate authorityCompany counselExecuted instrument and board approvals preserve US$12m cap, 6.25% initial ownership and 43.75m token entitlement.
CP2Security closureCTO / independent auditorRetest letter confirms no open critical or high finding; production deployment hash matches reviewed code.
CP3Custody and token controlsBoard / security lead2-of-3 multisig, qualified custodian for treasury keys, pause and key-rotation procedures active before TGE.
CP4Refreshed evidence and concentration covenantCFOClosing-date cash, liabilities, cap table, revenue bridge and customer concentration vary by no more than 5% from the reviewed record.
Funding rule. All four conditions require documentary closure. A waiver requires written IC approval; silence or partial delivery does not waive a condition.

IC decision record

Recommendation
Approve with conditions
Approved commitment
US$750,000
Instrument / cap
SAFT+T / US$12,000,000 post-money
Funding status
Pending CP1–CP4
Decision owner
Investment committee
Decision date
14 September 2026

The conditional pass rests on reconciled actuals plus the clearly labeled synthetic DR10 bridge. Legal, security, custody and closing-refresh conditions remain binding, and the token contributes no value.

Basis, method and limitations

This IC cover memorandum synthesizes the public-source screen, verification memorandum and evidence workbook. It applies a claim-to-evidence register, independent financial re-performance, explicit ownership and dilution math, separate treatment of company and token value, risk prioritization, alternative explanations and documentary closing conditions.

Package control. Case ASTER-20260914 · version 1.2 · evidence cutoff 14 September 2026 · evidence manifest SHA-256 fd4272efe1c5efdea3974525447809d95b6c7b8f720412a57f4418d366ff06ce.

It is a fictional specimen for a fictional commissioning investor. It is not a fairness opinion, audit, legal opinion or assurance engagement. The specialist opinions and executed closing documents remain conditions to funding.